Possible New Strategies for the Treatment of Congenital Hyperinsulinism
ObjectiveCongenital hyperinsulinism (CHI) is a rare disease characterized by persistent hypoglycemia as a result of inappropriate insulin secretion, which can lead to irreversible neurological defects in infants. Poor efficacy and strong adverse effects of the current medications impede successful t...
Main Authors: | Jelena Sikimic, Theresa Hoffmeister, Anne Gresch, Julia Kaiser, Winfried Barthlen, Carmen Wolke, Ilse Wieland, Uwe Lendeckel, Peter Krippeit-Drews, Martina Düfer, Gisela Drews |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.545638/full |
Similar Items
-
The molecular mechanisms, diagnosis and management of congenital hyperinsulinism
by: Senthil Senniappan, et al.
Published: (2013-01-01) -
Analysis on the pathogenic genes of 60 Chinese children with congenital hyperinsulinemia
by: Zi-Di Xu, et al.
Published: (2018-11-01) -
Neonatal diabetes and congenital hyperinsulinism caused by mutations in ABCC8/SUR1 are associated with altered and opposite affinities for ATP and ADP
by: Joseph eBryan, et al.
Published: (2015-04-01) -
Congenital hyperinsulinism: diagnostic and management challenges in a developing country – case report
by: Cheri Mathews John, et al.
Published: (2017-12-01) -
Hyperinsulinaemic Hypoglycaemia - The Molecular Mechanisms
by: Azizun eNessa, et al.
Published: (2016-03-01)